A review of the association between depression and insulin resistance: Pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes?

Current Psychiatry Reports

Volumn 14, Issue 1, 2012, Pages 8-14

  Silva, Naomi ^a   Atlantis, Evan ^b   Ismail, Khalida ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Depression; Diabetes; Homeostatic model assessment (HOMA); Hypothalamic pituitary adrenal (HPA) axis; Insulin resistance (IR); Prevention; Type 2 diabetes

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; INSULIN; MAPROTILINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ANXIETY DISORDER; CASE CONTROL STUDY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; GENETIC POLYMORPHISM; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MAJOR DEPRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SECONDARY ANALYSIS; VALIDITY; WEIGHT REDUCTION; EPIDEMIOLOGY; FEMALE; LIFESTYLE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE;

EID: 84857771624     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-011-0245-8     Document Type: Review

References (50)

1. World Health Organization. The global burden of disease: 2004 Update. WHO Press; 2008.
2. Egede LE, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002;25(3):464-70. (Pubitemid 41103337)
3. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130-9. (Pubitemid 44115261)
4. Nouwen A, Nefs G, Caramlau I, et al. Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes. Diabetes Care. 2011;34(3):752-762. This review shows that the prevalence of depression is similar in people with prediabetes compared with those with normal fasting plasma glucose and undiagnosed diabetes, but higher in people with known diabetes.
5. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49(5):837-45.
6. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-90.
7. Lawlor DA, Smith GD, Ebrahim S. British Women's Heart and Health study: association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health study. BMJ. 2003;327(7428):1383-4. (Pubitemid 37543947)
8. Timonen M, Rajala U, Jokelainen J, et al. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol Psychiatry. 2006;11(10):929-33. (Pubitemid 44470215)
9. Timonen M, Salmenkaita I, Jokelainen J, et al. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med. 2007;69(8):723-8. (Pubitemid 350287478)
10. Adriaanse MC, Dekker JM, Nijpels G, et al. Associations between depressive symptoms and insulin resistance: the Hoorn study. Diabetologia. 2006;49(12):2874-7. (Pubitemid 44730290)
11. Pan A, Ye X, Franco OH, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord. 2008;109(1-2):75-82.
12. Holt RI, Phillips DI, Jameson KA, et al. The relationship between depression and diabetes mellitus: findings from the Hertfordshire cohort study. Diabet Med. 2009;26(6):641-8.
13. Pearson S, Schmidt M, Patton G, et al. Depression and insulin resistance: cross sectional associations in young adults. Diabetes Care. 2010;33(5):1128-33.
14. Golden SH, Lee HB, Schreiner PJ, et al. Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med. 2007;69(6):529-36. (Pubitemid 47205736)
15. Roos C, Lidfeldt J, Agardh CD, et al. Insulin resistance and self-rated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study. Metab Clin Exp. 2007;56(6):825-9. (Pubitemid 46734090)
16. Shen Q, Bergquist-Beringer S, Sousa VD. Major depressive disorder and insulin resistance in nondiabetic young adults in the United States: the National Health and Nutrition Examination Survey, 1999-2002. Biological Research for Nursing 2010. [Epub ahead of print].
17. Lawlor DA, Ben-Shlomo Y, Ebrahim S, et al. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study. BMJ. 2005;330(7493):705-6. (Pubitemid 40470015)
18. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care. 2004;27(12):2856-62. (Pubitemid 39565049)
19. Chiba M, Suzuki S, Hinokio Y, et al. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metab Clin Exp. 2000;49(9):1145-9.
20. Hung YJ, Hsieh CH, Chen YJ, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol. 2007;67(5):784-9.
21. Okamura F, Tashiro A, Utumi A, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism. 2000;49(10):1255-160.
22. Kauffman RP, Castracane VD, White DL, et al. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecol Endocrinol. 2005;21(3):129-37. (Pubitemid 41597553)
23. Weber-Hamann B, Gilles M, Lederbogen F, et al. Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine. J Clin Psychiatry. 2006;67(12):1856-61. (Pubitemid 46048182)
24. Chen YC, Lin WW, Chen YJ, et al. Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators of Inflammation; 2010. [Epub 2010 May 18].
25. Atlantis E, Lange K, Goldney RD, et al. Specific medical conditions associated with clinically significant depressive symptoms in men. Soc Psychiatry Psychiatr Epidemiol 2010.
26. Barton DA, Dawood T, Lambert EA, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens. 2007;25:2117-24. (Pubitemid 47476310)
27. Bao AM, Meynen G, Swaab DF. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev. 2008;57:531-53. (Pubitemid 351381758)
28. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 2008;29:1110-a-1117. (Pubitemid 351844893)
29. Champeri Wand GS, Malhotra SS, et al. Biological basis of depression in adults with diabetes. Curr Diabetes Rep. 2010;10(6):396-405.
30. Pizzi C, Mancini S, Angeloni L, et al. Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther. 2009;86:527-32.
31. Buhl ES, Jensen TK, Jessen N, et al. Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. Am J Physiol Endocrinol Metab. 2010;298:E920-9.
32. Danese A, Pariante CM, Caspi A, et al. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA. 2007;104(4):1319-24. (Pubitemid 46184002)
33. Ismail K, Sloggett A, De Stavola B. Do common mental disorders increase cigarette smoking? Results from five waves of a population-based panel cohort study. Am J Epidemiol. 2000;152(7):651-7.
34. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220-229. This systematic review showed for the first time bidirectional associations between obesity and depression, and provides support for the hypothesis that lifestyle behaviors (unhealthy eating and physical inactivity) mediate the association between depression and diabetes.
35. Patton GC, Carlin JB, Coffey C, et al. Depression, anxiety, and smoking initiation: a prospective study over 3 years. Am J Public Health. 1998;88:1518-22. (Pubitemid 28455761)
36. van Gool CH, Kempen G I J M, Penninx B W J H, et al. Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing. 2003;32:81-7. (Pubitemid 36193243)
37. Patten SB, Williams J V A, Lavorato DH, Eliasziw M: A longitudinal community study of major depression and physical activity. General Hospital Psychiatry; 2009;31:571-575.
38. Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry. 2003;60:817-26. (Pubitemid 36960913)
39. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008;51:1356-67.
40. Drewnowski A. The real contribution of added sugars and fats to obesity. Epidemiol Rev. 2007;29:160-71. (Pubitemid 47229647)
41. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451-63. (Pubitemid 46669328)
42. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22:623-34.
43. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398-403.
44. Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166:2314-21. (Pubitemid 44833355)
45. Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidencebased treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010;303:1921-8.
46. Gilbody S, Bower P, Whitty P. Costs and consequences of enhanced primary care for depression: systematic review of randomised economic evaluations. Br J Psychiatry. 2006;189:297-308. (Pubitemid 44606742)
47. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-20.
48. Simon GE, Rohde P, Ludman EJ, et al. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen Hosp Psychiatry. 2010;32:583-9.
49. Ye Z, Chen L, Yang Z, et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One. 2011;6:e21551. This systematic review shows significant treatment effects of fluoxetine on reducing weight, triglyceride, and glycated hemoglobin levels in obese people with type 2 diabetes mellitus, which should be taken into account in the pharmacologic management of depression in individuals with excess body weight and diabetes.
50. Atlantis E, Goldney RD, Wittert GA. Obesity and depression or anxiety. BMJ. 2009;339:b3868.